Kyverna Therapeutics Inc. (KYTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.29
-0.04 (-1.20%)
At close: Jan 15, 2025, 3:59 PM
3.29
-0.03%
After-hours Jan 15, 2025, 04:00 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 |
Revenue | n/a | 7.03M | 5.66M |
Cost of Revenue | 1.71M | 1.05M | 586.00K |
Gross Profit | -1.71M | 5.97M | 5.07M |
Operating Income | -62.41M | -29.38M | -26.35M |
Interest Income | 2.28M | 565.00K | 1K |
Pretax Income | -60.37M | -28.89M | -26.35M |
Net Income | -60.37M | -28.89M | -26.35M |
Selling & General & Admin | 12.48M | 8.01M | 6.15M |
Research & Development | 49.92M | 28.40M | 25.85M |
Other Expenses | -55.00K | -9.00K | -2.00K |
Operating Expenses | 62.41M | 36.41M | 32.00M |
Interest Expense | 187.00K | 65.00K | 3.00K |
Selling & Marketing Expenses | n/a | n/a | n/a |
Cost & Expenses | 62.41M | 36.41M | 32.00M |
Income Tax | n/a | 56.00K | 1K |
Shares Outstanding (Basic) | 673.62M | 25.80M | 25.80M |
Shares Outstanding (Diluted) | 673.62M | 25.80M | 25.80M |
EPS (Basic) | -0.00 | -1.12 | -1.02 |
EPS (Diluted) | -0.00 | -1.12 | -1.02 |
EBITDA | -58.47M | -27.78M | -25.76M |
Depreciation & Amortization | 1.71M | 1.05M | 586.00K |